This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In the recent IDC FutureScape: Worldwide Health Industry 2021 Predictions report, experts at IDC Health Insights offer their thoughts about the issues healthcare and lifescience organizations will contend with over the next year and beyond. Here are IDC's 2021 predictions. WHY IT MATTERS. " ON THE RECORD.
The survey, commissioned by specialist insurer Beazley , focused on 376 executives from telehealth companies in Europe, North America and Asia, as well as mobile platforms and lifescience technology software. companies said they plan to raise capital in 2021, compared with 70% in the U.K. WHY IT MATTERS. Nearly nine in 10 U.S.
The Rise of At-Home Health Solutions: A Paradigm Shift The global pandemic catalyzed the home health sector, driving investments in remote healthcare solutions to unprecedented levels. billion in 2021. Before she started Mira, she was in business director roles in a Fortune 500 lifescience company, running a $100M global business.
Market Dynamics: Lower valuations: Compared to the heady days of 2021, HealthTech valuations have cooled down, making "soft landing" deals more attractive for both acquirers and targets. Pharmaceutical and LifeSciences Companies: These companies are looking for HealthTech solutions to: Enhance clinical trials and drug development processes.
Partner at Berger Singerman LLP Telehealth has revolutionized the delivery of outpatient mental health services, and there has been exponential growth in the acceptance and delivery of remotecare. No longer does a patient have to be sitting on a therapist’s couch to receive care. The sofa at home will work just fine.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content